NeueHealth (NEUE) Competitors $6.79 +0.06 (+0.89%) Closing price 07/25/2025 03:58 PM EasternExtended Trading$6.79 0.00 (0.00%) As of 07/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEUE vs. KINS, GOCO, HIT, RDZN, AAME, FGF, ZBAO, HUIZ, AIFU, and OXBRShould you be buying NeueHealth stock or one of its competitors? The main competitors of NeueHealth include Kingstone Companies (KINS), GoHealth (GOCO), Health In Tech (HIT), Roadzen (RDZN), Atlantic American (AAME), Fundamental Global (FGF), Zhibao Technology (ZBAO), Huize (HUIZ), AIFU (AIFU), and Oxbridge Re (OXBR). These companies are all part of the "insurance" industry. NeueHealth vs. Its Competitors Kingstone Companies GoHealth Health In Tech Roadzen Atlantic American Fundamental Global Zhibao Technology Huize AIFU Oxbridge Re Kingstone Companies (NASDAQ:KINS) and NeueHealth (NYSE:NEUE) are both small-cap insurance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends. Is KINS or NEUE more profitable? Kingstone Companies has a net margin of 12.25% compared to NeueHealth's net margin of -14.28%. Kingstone Companies' return on equity of 31.92% beat NeueHealth's return on equity.Company Net Margins Return on Equity Return on Assets Kingstone Companies12.25% 31.92% 5.58% NeueHealth -14.28%N/A -17.46% Does the media prefer KINS or NEUE? In the previous week, Kingstone Companies had 4 more articles in the media than NeueHealth. MarketBeat recorded 5 mentions for Kingstone Companies and 1 mentions for NeueHealth. Kingstone Companies' average media sentiment score of 0.76 beat NeueHealth's score of 0.00 indicating that Kingstone Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kingstone Companies 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeueHealth 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, KINS or NEUE? Kingstone Companies has higher earnings, but lower revenue than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than Kingstone Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKingstone Companies$169.88M1.30$18.36M$1.599.94NeueHealth$936.66M0.06-$134.68M-$22.00-0.31 Do analysts rate KINS or NEUE? NeueHealth has a consensus price target of $7.00, suggesting a potential upside of 3.09%. Given NeueHealth's stronger consensus rating and higher probable upside, analysts plainly believe NeueHealth is more favorable than Kingstone Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kingstone Companies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeueHealth 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, KINS or NEUE? Kingstone Companies has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Do insiders and institutionals have more ownership in KINS or NEUE? 14.9% of Kingstone Companies shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 5.1% of Kingstone Companies shares are owned by insiders. Comparatively, 63.3% of NeueHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryKingstone Companies beats NeueHealth on 9 of the 14 factors compared between the two stocks. Get NeueHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEUE vs. The Competition Export to ExcelMetricNeueHealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$60.08M$7.30B$5.69B$21.10BDividend YieldN/A2.84%4.58%3.59%P/E Ratio-0.3125.2828.1028.44Price / Sales0.0642.19432.4458.59Price / CashN/A26.7436.2222.92Price / Book-0.049.718.664.69Net Income-$134.68M$239.96M$3.25B$995.51M7 Day Performance-0.29%2.92%4.23%1.65%1 Month Performance-0.51%4.88%10.52%4.54%1 Year Performance12.60%15.47%34.41%9.99% NeueHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEUENeueHealth0.7921 of 5 stars$6.79+0.9%$7.00+3.1%+13.0%$60.08M$936.66M-0.311,252News CoverageKINSKingstone Companies2.3578 of 5 stars$15.63+3.2%N/A+150.0%$218.21M$155.14M9.8090Dividend AnnouncementGOCOGoHealth2.4439 of 5 stars$6.02+6.9%$18.00+199.0%-56.1%$143.24M$834.27M-5.032,261HITHealth In TechN/A$1.76+30.4%$2.50+42.0%N/A$96.22M$22.38M0.0079News CoverageEarnings ReportAnalyst UpgradeGap UpHigh Trading VolumeRDZNRoadzen3.3544 of 5 stars$1.08+0.5%$5.00+365.1%-7.8%$80.38M$44.30M-0.72324News CoveragePositive NewsGap UpAAMEAtlantic American0.9172 of 5 stars$2.19-2.2%N/A+38.8%$45.08M$191.36M-24.55140FGFFundamental Global2.8437 of 5 stars$26.93-3.7%N/A-19.7%$34.20M$17.35M20.559Positive NewsGap UpZBAOZhibao TechnologyN/A$0.96-2.7%N/A-73.6%$30.80M$25.27M0.00148HUIZHuize0.8969 of 5 stars$2.65-0.6%$2.30-13.3%-89.2%$26.53M$1.22B-6.261,640Positive NewsGap DownAIFUAIFUN/A$7.04+3.8%N/AN/A$20.42M$247.81M9.644,707Positive NewsOXBROxbridge Re2.1291 of 5 stars$2.34-4.1%$5.00+113.7%-40.4%$17.42M$1.36M-7.803 Related Companies and Tools Related Companies Kingstone Companies Alternatives GoHealth Alternatives Health In Tech Alternatives Roadzen Alternatives Atlantic American Alternatives Fundamental Global Alternatives Zhibao Technology Alternatives Huize Alternatives AIFU Alternatives Oxbridge Re Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NEUE) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
